536456 — R J Biotech Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | 28.45% | ||
Financial Summary
| Year End 31st Mar | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 88.87 | 101.16 | 133.83 | 157.96 | 138.97 | n/a | n/a | -2.46% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
RJ Biotech Limited (RJ Biotech) is an India-based Agri-biotechnology company focusing on crop genetics and developing superior hybrids. The Company is engaged in the research, crop improvement, production and marketing of superior hybrid seeds in approximately six field crops and 15 vegetable crops. It produces and deals primarily in seeds. Its products include field crops, vegetable crops and oil seed crops. Its field crops include Hybrid Bajra Amol, Hybrid Bajra RJBH-555, BG-II Cotton Hybrid Tukaram, Elite Paddy Janaki-1010, and Hybrid Paddy Chetak-115 (Maruti-115). It primarily develops hybrids with nutritional and economical traits in fiber crops, including cotton; cereal crops, such as paddy, maize and bajra, and vegetable crops. It has a collection over 2,700 varieties of germplasm in various crops. It also has approximately two processing plants with a capacity of 45,000 MT per annum, three product testing locations and has a storage facility of approximately 40,000 square feet.
Directors
- Harshwardhan Joshi CHM (30)
- Yogesh Shelke CFO
- Ruchita Zalte CCO (32)
- Aditi Joshi DRC
- Balram Yerme IND
- Prashant Sukla NID
- Last Annual
- March 31st, 2022
- Last Interim
- September 30th, 2022
- Incorporated
- December 28th, 2005
- Public Since
- September 25th, 2013
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 9,467,600
- Address
- Siddharth Arcade, Railway Station Road,, AURANGABAD, 431005
- Web
- https://www.rjbiotech.com/
- Phone
- +91 2402354912
- Auditors
- M/S. S M Bangad & Co.
Upcoming Events for 536456
Similar to 536456
Aelea Commodities
Bombay Stock Exchange
Ajanta Soya
Bombay Stock Exchange
Alna Trading and Exports
Bombay Stock Exchange
Ambar Protein Industries
Bombay Stock Exchange
Ambo Agritec
Bombay Stock Exchange
FAQ
As of Today at 22:58 UTC, shares in R J Biotech are trading at IN₹3.43. This share price information is delayed by 15 minutes.
Shares in R J Biotech last closed at IN₹3.43 and the price had moved by -30% over the past 365 days. In terms of relative price strength the R J Biotech share price has underperformed the S&P BSE 100 Index by -34.06% over the past year.
There is no consensus recommendation for this security.
Find out moreR J Biotech does not currently pay a dividend.
R J Biotech does not currently pay a dividend.
R J Biotech does not currently pay a dividend.
To buy shares in R J Biotech you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹3.43, shares in R J Biotech had a market capitalisation of .
Here are the trading details for R J Biotech:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 536456
Based on an overall assessment of its quality, value and momentum R J Biotech is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like R J Biotech. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -23.52%.
As of the last closing price of IN₹3.43, shares in R J Biotech were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The R J Biotech PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹3.43.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
R J Biotech's management team is headed by:
- Harshwardhan Joshi - CHM
- Yogesh Shelke - CFO
- Ruchita Zalte - CCO
- Aditi Joshi - DRC
- Balram Yerme - IND
- Prashant Sukla - NID